GBO Medical Systems
Medical device distributor and service provider established in 1985, focused on supplying intensive-care respiratory devices and consumables to the Turkish healthcare market. Product categories include invasive and noninvasive ventilators, high-flow nasal cannula systems, active heated humidifiers, neonatal respiratory support systems (bubble CPAP), bedside patient monitors, and related consumables. The company maintains product regulatory documentation for CE marking and references ISO 13485 for some products, and provides technical service, clinician education materials and curated clinical literature.
Industries
Nr. of Employees
small (1-50)
GBO Medical Systems
Konaklar Mah. Cad. No 22/1 4.Levent-Beşiktaş, İstanbul, Turkey
Products
ICU ventilators (invasive and noninvasive)
Ventilators for invasive mechanical ventilation and noninvasive support with multiple ventilation modes used in critical care and post‑extubation management.
High-flow nasal cannula (HFNC) systems and accessories
High-flow oxygen delivery devices and consumables including nasal cannulae and compatible heated circuits for HFNC therapy.
Active heated humidifiers and heated patient circuits
Heated humidification devices and heated-wire circuits designed to warm and humidify inspired gas for invasive/noninvasive ventilation and HFNC; includes temperature and humidity monitoring.
Nebulization accessories and HFNC aerosol guidance
Selection of nebulizers (including vibrating mesh technology), adapters and guidance materials addressing the effects of flow and humidity on aerosol deposition during HFNC therapy.
Neonatal respiratory systems and accessories
Infant bubble CPAP systems, neonatal nasal prongs, neonatal heated circuits and pressure-safety accessories for neonatal respiratory support.
Patient monitors and noninvasive hemodynamic monitors
Multi-parameter bedside monitors with ECG, SpO2, NIBP, EtCO2 and temperature monitoring, and portable noninvasive hemodynamic monitoring devices for ICU and perioperative use.
ICU ventilators (invasive and noninvasive)
Ventilators for invasive mechanical ventilation and noninvasive support with multiple ventilation modes used in critical care and post‑extubation management.
High-flow nasal cannula (HFNC) systems and accessories
High-flow oxygen delivery devices and consumables including nasal cannulae and compatible heated circuits for HFNC therapy.
Active heated humidifiers and heated patient circuits
Heated humidification devices and heated-wire circuits designed to warm and humidify inspired gas for invasive/noninvasive ventilation and HFNC; includes temperature and humidity monitoring.
Nebulization accessories and HFNC aerosol guidance
Selection of nebulizers (including vibrating mesh technology), adapters and guidance materials addressing the effects of flow and humidity on aerosol deposition during HFNC therapy.
Neonatal respiratory systems and accessories
Infant bubble CPAP systems, neonatal nasal prongs, neonatal heated circuits and pressure-safety accessories for neonatal respiratory support.
Patient monitors and noninvasive hemodynamic monitors
Multi-parameter bedside monitors with ECG, SpO2, NIBP, EtCO2 and temperature monitoring, and portable noninvasive hemodynamic monitoring devices for ICU and perioperative use.
Services
Commercial supply of ventilators, HFNC systems, humidifiers, neonatal respiratory systems, monitors and related consumables to hospitals and clinics; support for procurement and public tender participation.
On-site and remote technical assistance, preventive maintenance, repair coordination and spare-parts provision for distributed medical devices with dedicated service contacts.
Provision of clinician-oriented educational content, summaries of peer‑reviewed research, downloadable open-access articles and participation in national clinical congresses and training programs.
Commercial supply of ventilators, HFNC systems, humidifiers, neonatal respiratory systems, monitors and related consumables to hospitals and clinics; support for procurement and public tender participation.
On-site and remote technical assistance, preventive maintenance, repair coordination and spare-parts provision for distributed medical devices with dedicated service contacts.
Provision of clinician-oriented educational content, summaries of peer‑reviewed research, downloadable open-access articles and participation in national clinical congresses and training programs.
Expertise Areas
- Respiratory care device distribution (ICU and noninvasive)
- High-flow nasal cannula therapy and HFNC-related aerosol delivery
- Noninvasive ventilation and post‑extubation strategies
- Neonatal respiratory support (bubble CPAP and neonatal circuits)
Key Technologies
- High-flow nasal cannula (HFNC) systems
- Noninvasive ventilation (NIV)
- Invasive mechanical ventilators
- Active heated humidifiers
News & Updates
Company participation at the 20th National Uludağ Pediatric Winter Congress.
Participation in the 22nd National Intensive Care Congress.
Published interview addressing ventilator use in intensive care (web article on company site).
Hosted summary and downloadable open-access article reviewing aerosol delivery via high-flow nasal cannula, discussing effects of flow and humidity on trans-nasal aerosol deposition and practical implications for clinical dosing.
Link and summary of a multicenter randomized clinical trial comparing HFNC combined with NIV versus HFNC alone for postextubation outcomes (JAMA, 2019).
Open-access protocol summary for a multicenter randomized trial comparing HFNC alone versus HFNC with NIV sessions during the postextubation period in high-risk ICU patients; includes trial design, outcomes and stratification criteria.
Company participation at the 20th National Uludağ Pediatric Winter Congress.
Participation in the 22nd National Intensive Care Congress.
Published interview addressing ventilator use in intensive care (web article on company site).
Hosted summary and downloadable open-access article reviewing aerosol delivery via high-flow nasal cannula, discussing effects of flow and humidity on trans-nasal aerosol deposition and practical implications for clinical dosing.
Link and summary of a multicenter randomized clinical trial comparing HFNC combined with NIV versus HFNC alone for postextubation outcomes (JAMA, 2019).
Open-access protocol summary for a multicenter randomized trial comparing HFNC alone versus HFNC with NIV sessions during the postextubation period in high-risk ICU patients; includes trial design, outcomes and stratification criteria.